Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and suppressing https://sashatpqm171283.blogsumer.com/34837119/comprehending-semaglutide-a-comprehensive-guide